Background: CASTLE (carcinoma showing thymus-like differentiation) is a rare tumor (accounting for less than 0.15% of thyroid neoplasms) with most of the reported cases from Asia. Although this tumor is rare, distinguishing it from more aggressive neoplasms is critical because of its improved prognosis. To date, there have been limited studies on its cytomorphological features. Herein, we review the cytomorphological features of 10 fine-needle aspiration (FNA) cases of histologically confirmed CASTLE and discuss the findings in light of the current literature. Methods: We retrospectively (1989-2016) identified 10 cases of CASTLE from 17,415 surgical cases of thyroid carcinoma from The Johns Hopkins Hospital and Fudan University Shanghai Cancer Center. The cases were reviewed for discrete cytomorphological characteristics. Results: All of the cases displayed predominantly single (dishesive) epithelial cell populations, high nuclear/cytoplasmic ratios, hyperchromatic to open/vesicular nuclei and macronucleoli. The majority of cases additionally showed hypercellular, three-dimensional fragments in a background of lymphocytes. The fragments displayed syncytial architecture without molding and rarely squamous differentiation. All cases lacked follicular differentiation, intranuclear inclusions, nuclear molding, or neuroendocrine-type chromatin. Conclusions: Cytopathological features alone do not appear to be distinctive or definitive of CASTLE but rather allow for the inclusion of CASTLE within the differential diagnosis. Procurement of cell block material is important and resulted in the single case of CASTLE accurately diagnosed on FNA. Cytopathological features that favored CASTLE included syncytial fragments of malignant cells with pleomorphic large nuclei, vesicular chromatin, and prominent nucleoli in a background of lymphocytes. These cytopathological findings in the appropriate clinicoradiological context warrant its inclusion in the reported differential diagnosis in order to be able to implement appropriate clinical management.

1.
Miyauchi A, Kuma K, Matsuzuka F, et al: Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid. World J Surg 1985;9:128-135.
2.
Chan JKC, Rosai J: Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 1991;22:349-367.
3.
Cheuk W, Chan JKC, Dorfman DM, et al: Spindle cell tumour with thymus-like differentiation; in DeLellis RA, Lloyd RV, Heitz PU, et al (eds): Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours. Lyon, IARC Press, 2004, pp 96-97.
4.
Huang CY, Wang L, Wang Y, et al: Carcinoma showing thymus-like differentiation of the thyroid (CASTLE). Pathol Res Pract 2013;209:662-665.
5.
Kakudo K, Bai Y, Ozaki T, et al: Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid. Histol Histopathol 2013;30:543-556.
6.
Reimann JD, Dorfman DM, Nose V: Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 2006;30:994-1001.
7.
Ito Y, Miyauchi A, Nakamura Y, et al: Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of the Japanese Society of Thyroid Surgery. Am J Clin Pathol 2007;127:230-236.
8.
Hirokawa M, Kuma S, Miyauchi A: Cytologic findings of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a study of eight cases. Diagn Cytopathol 2012;40:E16-E20.
9.
Piacentini MG, Romano F, De Fina S, et al: Carcinoma of the neck showing thymic-like elements (CASTLE): report of a case and review of the literature. Int J Surg Pathol 2006;14:171-175.
10.
Chow SM, Chan, JKC, Tse LLY, et al: Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease. Eur J Surg Oncol 2007;33:83-85.
11.
Dorfman DM, Shahsafaei A, Miyauchi A: Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD immunoreactivity: new evidence for thymic differentiation. Histopathology 1998;32:104-109.
12.
Roka S, Kornek G, Schuller J, et al: Carcinoma showing thymic like-like elements: a rare malignancy of the thyroid gland. Br J Surg 2004;91:142-145.
13.
Youens KE, Bean SM, Dodd LG, et al: Thyroid carcinoma showing thymus-like differentiation (CASTLE): case report with cytomorphology and review of the literature. Am J Clin Pathol 2011;39:204-209.
14.
Ahuja AT, Chan ES, Allen PW, et al: Carcinoma showing thymic-like differentiation (CASTLE tumor). AJNR Am J Neuroradiol 1998;19:1225-1228.
15.
Liu Z, Teng XY, Sun DX, et al: Clinical analysis of thyroid carcinoma showing thymus-like differentiation: report of 8 cases. Int Surg 2013;98:95-100.
16.
Wang YF, Liu B, Fan XS, et al: A clinicopathologic, immunohistochemical, ultrastructural and molecular analysis. Am J Clin Pathol 2015;143:223-233.
17.
Reimann JD, Dorfman DM, Nosé V: Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 2006;30:994-1001.
18.
Pusztaszeri M, Yerly S, Lobrinus JA, et al: Carcinoma showing thymus-like elements of the thyroid (CASTLE) arising in close association of solid cell nests. Evidence for a precursor lesion? Thyroid 2012;23:511-516.
19.
Chan JKC: Tumors of the thyroid and parathyroid glands; in Fletcher CDM (ed): Diagnostic Histopathology of Tumors. Philadelphia, Churchill Livingstone, 2007, pp 1048-1049.
20.
Chang S, Joo M, Kim H: Cytologic findings of thyroid carcinoma showing thymus-like differentiation: a case report. Korean J Pathol 2012;46:302-305.
21.
Nassar A, Saqi A, Baloch Z, et al: Carcinoma showing thymus like element of the thyroid. Acta Cytol 2003;47:313-315.
22.
Ng WK, Collins, RJ, Shek WH, et al: Cytologic diagnosis of ‘CASTLE' of thyroid gland: report of a case with histologic correlation. Diagn Cytopathol 1996;15:224-227.
23.
Youens KE, Bean SM, Dodd LG, et al: Thyroid carcinoma showing thymus-like differentiation (CASTLE): case report with cytomorphology and review of the literature. Diagn Cytopathol 2010;39:204-209.
24.
Alifano M, Boudaya MS, Dinu C, et al: Carcinoma showing thymus-like elements invading the trachea. J Thorac Cardiovasc Surg 2006;38:541-544.
25.
Yamazaki M, Fujii S, Daikoo H, et al: Carcinoma showing thymus-like differentiation (CASTLE) with neuroendocrine differentiation. Pathol Int 2008;58:775-779.
26.
Chan LP, Chiang FY, Lee, KW, et al: Carcinoma showing thymus-like differentiation (CASTLE) of thyroid: a case report and literature review. Kaohsiung J Med Sci 2008;24:591-597.
27.
Mizukami Y, Kurumaya H, Yamada T, et al: Thymic carcinoma involving the thyroid gland: report of two cases. Hum Pathol 1995;5:576-579.
28.
Damiani S, Filotico M, Eusebi V: Carcinoma of the thyroid showing thymoma-like features. Virchows Arch A Pathol Anat Histopathol 1991;418:463-466.
29.
Rosai J, Carcangiu ML, Delellis RA: Atlas of Tumor Pathology, Fascicle 5. Tumors of the Thyroid Gland. 3rd Series. Washington, Armed Forces Institute of Pathology, 1992, pp 284-285.
30.
Kusada N, Hara Y, Kobayashi S, et al: A case of aggressive carcinoma showing thymus-like differentiation with distant metastases. Thyroid 2005;15:1383-1388.
31.
Luo CM, Hseuh C, Chen TM: Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor - a new case report and review of literature. Head Neck 2005;27:927-933.
32.
Sun T, Wang Z, Wang J, et al: Outcome of radical resection and postoperative radiotherapy for thyroid carcinoma showing thymus-like differentiation. World J Surg 2011;35:1840-1846.
33.
Abeni C, Ogliosi C, Rota L: Thyroid carcinoma showing thymus-like differentiation: case presentation of a young man. World J Clin Oncol 2014;5:1117-1120.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.